Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Qu, Wen sheng ^a   Tian, Dai shi ^a   Guo, Zhi bao ^a   Fang, Jun ^a   Zhang, Qiang ^a   Yu, Zhi yuan ^a   Xie, Min jie ^a   Zhang, Hua qiu ^a   Lü, Jia gao ^a   Wang, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Epidermal growth factor receptor; Microglia; Neuroinflammation; Spinal cord injury

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CETUXIMAB; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCENT DYE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL STRUCTURE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRY WEIGHT; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIA CELL; MALE; MICROGLIA; NERVE FIBER GROWTH; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; WESTERN BLOTTING;

EID: 84865161494     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-178     Document Type: Article

References (72)

1. Ambrozaitis KV, Kontautas E, Spakauskas B, Vaitkaitis D. Pathophysiology of acute spinal cord injury. Medicina (Kaunas) 2006, 42:255-261.
2. Qiao F, Atkinson C, Kindy MS, Shunmugavel A, Morgan BP, Song H, Tomlinson S. The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury. Am J Pathol 2010, 177:3061-3070. 10.2353/ajpath.2010.100158, 2993269, 20952585.
3. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447. 10.1093/brain/awp322, 2858013, 20085927.
4. Beattie MS. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med 2004, 10:580-583. 10.1016/j.molmed.2004.10.006, 15567326.
5. Chan CC. Inflammation: beneficial or detrimental after spinal cord injury?. Recent Pat CNS Drug Discov 2008, 3:189-199. 10.2174/157488908786242434, 18991808.
6. Loane DJ, Byrnes KR. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7:366-377. 10.1016/j.nurt.2010.07.002, 2948548, 20880501.
7. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 1999, 158:351-365. 10.1006/exnr.1999.7118, 10415142.
8. Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, Steeves JD, Ramer MS, Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 2004, 24:2182-2190. 10.1523/JNEUROSCI.5275-03.2004, 14999069.
9. Tian DS, Xie MJ, Yu ZY, Zhang Q, Wang YH, Chen B, Chen C, Wang W. Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. Brain Res 2007, 1135:177-185.
10. Fischer OM, Hart S, Ullrich A. Dissecting the epidermal growth factor receptor signal transactivation pathway. Methods Mol Biol 2006, 327:85-97.
11. Jung HW, Son HY, Minh CV, Kim YH, Park YK. Methanol extract of Ficus leaf inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated microglia via the MAPK pathway. Phytother Res 2008, 22:1064-1069. 10.1002/ptr.2442, 18546149.
12. Bachstetter AD, Xing B, de Almeida L, Dimayuga ER, Watterson DM, Van Eldik LJ. Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta). J Neuroinflammation 2011, 8:79. 10.1186/1742-2094-8-79, 3142505, 21733175.
13. Gomez-Pinilla F, Knauer DJ, Nieto-Sampedro M. Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization. Brain Res 1988, 438:385-390.
14. Erschbamer M, Pernold K, Olson L. Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury. J Neurosci 2007, 27:6428-6435. 10.1523/JNEUROSCI.1037-07.2007, 17567803.
15. Liu B, Neufeld AH. Activation of epidermal growth factor receptor causes astrocytes to form cribriform structures. Glia 2004, 46:153-168. 10.1002/glia.10358, 15042583.
16. Nolte C, Kirchhoff F, Kettenmann H. Epidermal growth factor is a motility factor for microglial cells in vitro: Evidence for EGF receptor expression. Eur J Neurosci 1997, 9:1690-1698. 10.1111/j.1460-9568.1997.tb01526.x, 9283823.
17. Planas AM, Justicia C, Soriano MA, Ferrer I. Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia 1998, 23:120-129. 10.1002/(SICI)1098-1136(199806)23:2<120::AID-GLIA3>3.0.CO;2-A, 9600380.
18. Parker WE, Orlova KA, Heuer GG, Baybis M, Aronica E, Frost M, Wong M, Crino PB. Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex. Am J Pathol 2011, 178:296-305. 10.1016/j.ajpath.2010.11.031, 3069836, 21224066.
19. Ferrer I, Alcantara S, Ballabriga J, Olive M, Blanco R, Rivera R, Carmona M, Berruezo M, Pitarch S, Planas AM. Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain. Prog Neurobiol 1996, 49:99-123. 10.1016/0301-0082(96)00009-3, 8844822.
20. Luwor RB, Lu Y, Li X, Mendelsohn J, Fan Z. The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression. Oncogene 2005, 24:4433-4441. 10.1038/sj.onc.1208625, 15806152.
21. Ellis AG, Doherty MM, Walker F, Weinstock J, Nerrie M, Vitali A, Murphy R, Johns TG, Scott AM, Levitzki A, McLachlan G, Webster LK, Burgess AW, Nice EC. Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochem Pharmacol 2006, 71:1422-1434. 10.1016/j.bcp.2006.01.020, 16522318.
22. Gingras M, Gagnon V, Minotti S, Durham HD, Berthod F. Optimized protocols for isolation of primary motor neurons, astrocytes and microglia from embryonic mouse spinal cord. J Neurosci Methods 2007, 163:111-118. 10.1016/j.jneumeth.2007.02.024, 17445905.
23. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 1992, 31:616-621. 10.1002/jnr.490310405, 1578513.
24. Sheng W, Zong Y, Mohammad A, Ajit D, Cui J, Han D, Hamilton JL, Simonyi A, Sun AY, Gu Z, Hong JS, Weisman GA, Sun GY. Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia. J Neuroinflammation 2011, 8:121. 10.1186/1742-2094-8-121, 3206447, 21943492.
25. Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem 2009, 284:28319-28331. 10.1074/jbc.M109.024406, 2788882, 19696026.
26. Hsu CY, Hogan EL, Gadsden RH, Spicer KM, Shi MP, Cox RD. Vascular permeability in experimental spinal cord injury. J Neurol Sci 1985, 70:275-282. 10.1016/0022-510X(85)90169-8, 4056823.
27. Hsu JY, Xu XM. Early profiles of axonal growth and astroglial response after spinal cord hemisection and implantation of Schwann cell-seeded guidance channels in adult rats. J Neurosci Res 2005, 82:472-483. 10.1002/jnr.20662, 16240391.
28. Wong JK, Sharp K, Steward O. A straight alley version of the BBB locomotor scale. Exp Neurol 2009, 217:417-420. 10.1016/j.expneurol.2009.03.037, 2703578, 19348792.
29. Kerasidis H, Wrathall JR, Gale K. Behavioral assessment of functional deficit in rats with contusive spinal cord injury. J Neurosci Methods 1987, 20:167-179. 10.1016/0165-0270(87)90048-3, 3600032.
30. Abd-el-Basset E, Fedoroff S. Effect of bacterial wall lipopolysaccharide (LPS) on morphology, motility, and cytoskeletal organization of microglia in cultures. J Neurosci Res 1995, 41:222-237. 10.1002/jnr.490410210, 7650758.
31. Xu L, Huang Y, Yu X, Yue J, Yang N, Zuo P. The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury. Anesth Analg 2007, 105:1838-1844. table of contents, 10.1213/01.ane.0000287660.29297.7b, 18042890.
32. Kim SH, Smith CJ, Van Eldik LJ. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging 2004, 25:431-439. 10.1016/S0197-4580(03)00126-X, 15013563.
33. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H, Tsushima T, Akanuma Y, Fujita T, Komuro I, Yazaki Y, Kadowaki T. Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocr J 1998, 45(Suppl):S27-S31. 10.1507/endocrj.45.Suppl_S27, 9790226.
34. Goel S, Hidalgo M, Perez-Soler R. EGFR inhibitor-mediated apoptosis in solid tumors. J Exp Ther Oncol 2007, 6:305-320.
35. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl 2006, 96:444-450. 10.1007/3-211-30714-1_91, 16671502.
36. John GR, Lee SC, Brosnan CF. Cytokines: powerful regulators of glial cell activation. Neuroscientist 2003, 9:10-22. 10.1177/1073858402239587, 12580336.
37. Rasouli A, Bhatia N, Dinh P, Cahill K, Suryadevara S, Gupta R. Resection of glial scar following spinal cord injury. J Orthop Res 2009, 27:931-936. 10.1002/jor.20793, 2696557, 19062171.
38. Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: a review. Glia 1988, 1:301-307. 10.1002/glia.440010502, 2976393.
39. Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, Simpson EP, Yen AA, Xiao Q, Appel SH. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 2004, 63:964-977.
40. Morino T, Ogata T, Horiuchi H, Takeba J, Okumura H, Miyazaki T, Yamamoto H. Delayed neuronal damage related to microglia proliferation after mild spinal cord compression injury. Neurosci Res 2003, 46:309-318. 10.1016/S0168-0102(03)00095-6, 12804792.
41. Chi LY, Yu J, Zhu H, Li XG, Zhu SG, Kindy MS. The dual role of tumor necrosis factor-alpha in the pathophysiology of spinal cord injury. Neurosci Lett 2008, 438:174-179. 10.1016/j.neulet.2008.04.043, 18468795.
42. Yang L, Jones NR, Blumbergs PC, Van Den Heuvel C, Moore EJ, Manavis J, Sarvestani GT, Ghabriel MN. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 2005, 12:276-284. 10.1016/j.jocn.2004.06.011, 15851082.
43. Liu S, Xu GY, Johnson KM, Echetebu C, Ye ZS, Hulsebosch CE, McAdoo DJ. Regulation of interleukin-1beta by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous neuroprotection. Brain Res 2008, 1231:63-74.
44. Zong S, Zeng G, Wei B, Xiong C, Zhao Y. Beneficial effect of interleukin-1 receptor antagonist protein on spinal cord injury recovery in the rat. Inflammation 2011, 35:520-526.
45. Marchand F, Tsantoulas C, Singh D, Grist J, Clark AK, Bradbury EJ, McMahon SB. Effects of etanercept and minocycline in a rat model of spinal cord injury. Eur J Pain 2009, 13:673-681. 10.1016/j.ejpain.2008.08.001, 18849175.
46. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C, Bramanti P, Cuzzocrea S. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 2006, 316:1006-1016.
47. Chen KB, Uchida K, Nakajima H, Yayama T, Hirai T, Watanabe S, Guerrero AR, Kobayashi S, Ma WY, Liu SY, Baba H. Tumor necrosis factor-alpha antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila Pa 1976) 2011, 36:1350-1358.
48. Genovese T, Esposito E, Mazzon E, Muia C, Di Paola R, Meli R, Bramanti P, Cuzzocrea S. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury. J Pharmacol Exp Ther 2008, 325:100-114. 10.1124/jpet.107.131060, 18180375.
49. Horiuchi H, Ogata T, Morino T, Chuai M, Yamamoto H. Continuous intrathecal infusion of SB203580, a selective inhibitor of p38 mitogen-activated protein kinase, reduces the damage of hind-limb function after thoracic spinal cord injury in rat. Neurosci Res 2003, 47:209-217. 10.1016/S0168-0102(03)00216-5, 14512145.
50. Koistinaho M, Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 2002, 40:175-183. 10.1002/glia.10151, 12379905.
51. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 1998, 10:205-219. 10.1016/S0955-0674(98)80143-9, 9561845.
52. Benakis C, Bonny C, Hirt L. JNK inhibition and inflammation after cerebral ischemia. Brain Behav Immun 2010, 24:800-811. 10.1016/j.bbi.2009.11.001, 19903520.
53. Xu Z, Wang BR, Wang X, Kuang F, Duan XL, Jiao XY, Ju G. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. Life Sci 2006, 79:1895-1905. 10.1016/j.lfs.2006.06.023, 16978658.
54. Wang XJ, Kong KM, Qi WL, Ye WL, Song PS. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol Sin 2005, 26:934-942. 10.1111/j.1745-7254.2005.00152.x, 16038625.
55. Gwak YS, Unabia GC, Hulsebosch CE. Activation of p-38alpha MAPK contributes to neuronal hyperexcitability in caudal regions remote from spinal cord injury. Exp Neurol 2009, 220:154-161. 10.1016/j.expneurol.2009.08.012, 3008350, 19699199.
56. Yan Z, Stapleton PP, Freeman TA, Fuortes M, Daly JM. Enhanced expression of cyclooxygenase-2 and prostaglandin E2 in response to endotoxin after trauma is dependent on MAPK and NF-kappaB mechanisms. Cell Immunol 2004, 232:116-126. 10.1016/j.cellimm.2005.03.001, 15890324.
57. Rohl C, Lucius R, Sievers J. The effect of activated microglia on astrogliosis parameters in astrocyte cultures. Brain Res 2007, 1129:43-52.
58. Kyrkanides S, Olschowka JA, Williams JP, Hansen JT, O'Banion MK. TNF alpha and IL-1beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury. J Neuroimmunol 1999, 95:95-106. 10.1016/S0165-5728(98)00270-7, 10229119.
59. Suzumura A, Sawada M, Mokuno K, Kato K, Marunouchi T, Yamamoto H. Effects of microglia-derived cytokines on astrocyte proliferation. Restor Neurol Neurosci 1993, 5:347-352.
60. Codeluppi S, Svensson CI, Hefferan MP, Valencia F, Silldorff MD, Oshiro M, Marsala M, Pasquale EB. The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord. J Neurosci 2009, 29:1093-1104. 10.1523/JNEUROSCI.4103-08.2009, 2682457, 19176818.
61. Agrawal SK, Fehlings MG. Mechanisms of secondary injury to spinal cord axons in vitro: role of Na+, Na(+)-K(+)-ATPase, the Na(+)-H + exchanger, and the Na(+)-Ca2+ exchanger. J Neurosci 1996, 16:545-552.
62. Fitch MT, Doller C, Combs CK, Landreth GE, Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 1999, 19:8182-8198.
63. Cerniglia GJ, Pore N, Tsai JH, Schultz S, Mick R, Choe R, Xing X, Durduran T, Yodh AG, Evans SM, Koch CJ, Hahn SM, Quon H, Sehgal CM, Lee WM, Maity A. Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One 2009, 4:e6539. 10.1371/journal.pone.0006539, 2716529, 19657384.
64. Li ZW, Tang RH, Zhang JP, Tang ZP, Qu WS, Zhu WH, Li JJ, Xie MJ. Tian DS 2011, Inhibiting epidermal growth factor receptor attenuates reactive astrogliosis and improves functional outcome after spinal cord injury in rats. Neurochem Int, Wang W, [Epub ahead of print].
65. Koprivica V, Cho KS, Park JB, Yiu G, Atwal J, Gore B, Kim JA, Lin E, Tessier-Lavigne M, Chen DF, He Z. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 2005, 310:106-110. 10.1126/science.1115462, 16210539.
66. Sun D, Bullock MR, Altememi N, Zhou Z, Hagood S, Rolfe A, McGinn MJ, Hamm R, Colello RJ. The effect of epidermal growth factor in the injured brain after trauma in rats. J Neurotrauma 2010, 27:923-938. 10.1089/neu.2009.1209, 2943945, 20158379.
67. Ahmed Z, Jacques SJ, Berry M, Logan A. Epidermal growth factor receptor inhibitors promote CNS axon growth through off-target effects on glia. Neurobiol Dis 2009, 36:142-150. 10.1016/j.nbd.2009.07.016, 19632327.
68. Che Q, Carmines PK. Angiotensin II triggers EGFR tyrosine kinase-dependent Ca2+ influx in afferent arterioles. Hypertension 2002, 40:700-706. 10.1161/01.HYP.0000035524.10948.93, 12411465.
69. Karkoulias G, Mastrogianni O, Lymperopoulos A, Paris H, Flordellis C. alpha(2)-Adrenergic receptors activate MAPK and Akt through a pathway involving arachidonic acid metabolism by cytochrome P450-dependent epoxygenase, matrix metalloproteinase activation and subtype-specific transactivation of EGFR. Cell Signal 2006, 18:729-739. 10.1016/j.cellsig.2005.06.014, 16098714.
70. Junier MP, Hill DF, Costa ME, Felder S, Ojeda SR. Hypothalamic lesions that induce female precocious puberty activate glial expression of the epidermal growth factor receptor gene: differential regulation of alternatively spliced transcripts. J Neurosci 1993, 13:703-713.
71. Nieto-Sampedro M, Gomez-Pinilla F, Knauer DJ, Broderick JT. Epidermal growth factor receptor immunoreactivity in rat brain astrocytes. Response to injury. Neurosci Lett 1988, 91:276-282.
72. Birecree E, Whetsell WO, Stoscheck C, Jr King LE, Nanney LB. Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease. J Neuropathol Exp Neurol 1988, 47:549-560. 10.1097/00005072-198809000-00006, 3049945.